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Structural studies on photoreceptor phosphodiester-
ases type 6 (PDE6s) have been hampered by an inability
to express and purify substantial amounts of enzyme.
Here we describe bacterial expression and characteriza-
tion of the chicken cone PDE6 regulatory GAF-A and
GAF-B domains. High affinity cGMP binding was found
only for GAF-A as predicted from sequence alignments
with the GAF domains of PDE2 and PDE5. A homology
model of the GAF-A domain of chicken cone PDE6 based
on the crystal structure of mouse PDE2A GAF-B was
used to identify residues likely to make contact with
cGMP. Alanine mutagenesis of 4 of these residues
(F123A, D169A, T172A, and T176A) showed that each was
absolutely required for cGMP binding. Three of these
residues map to the H4 helical structure of the GAF-A
domain indicating this region as a key structural com-
ponent for cGMP binding. Mutagenesis of another resi-
due, S97A, decreased cGMP binding affinity 5-fold. Fi-
nally mutagenesis of Glu-124 indicated that it is
responsible for part but not all of the high specificity for
cGMP binding to PDE6 GAF-A. Since little data is avail-
able on the properties of the chicken cone PDE6 holoen-
zyme, we also characterized the native PDEs of chicken
retina. Two histone-activated PDE6 peaks were sepa-
rated by ion exchange chromatography and identified
by mass spectrometry as cone and rod photoreceptor
PDE6s, respectively. Both of these PDEs had cGMP
binding and kinetic properties similar to their corre-
sponding bovine photoreceptor PDEs. Moreover the
cGMP binding properties of chicken cone PDE6 holoen-
zyme were very similar to those of the bacterially ex-
pressed individual GAF-A or GAF-A/B domains.
There are two classes of photoreceptors, cones and rods, that
differ substantially in their response to light (1–3). Rods are
very sensitive to low levels of light and can respond to a single
photon. Cones are about 100 times less sensitive but respond
faster, and the light signal can be terminated more rapidly
than in rods (3, 4). Both rod and cone photoreceptors can sense
and respond to changes of light through a G-protein-mediated
signaling cascade that activates a family of cGMP-specific
phosphodiesterases, PDE6s.1 Activation of these PDEs de-
creases the level of cGMP and thereby modulates the activity of
a cyclic nucleotide-gated cation channel. This in turn controls
the release of neurotransmitter from the photoreceptor neuron.
Therefore, PDE6s play a crucial role in both rod and cone
phototransduction.
The rod PDE6 holoenzyme has been characterized as a het-
erotetramer containing one -subunit (PDE6A), one -subunit
(PDE6B), and two -subunits (5). Cone PDE6 is composed of
two identical -subunits (PDE6C) and two -subunits (6). The
-, -, and -subunits contain the catalytic sites that hydrolyze
cGMP. The -subunits bind to the holoenzyme and inhibit
phosphodiesterase activity. Cone and some rod PDE6s also
contain a -subunit that may target the normally membrane-
bound PDE6 to the cytosol (7, 8). However, the -subunit is also
a component of several other proteins and therefore not unique
to photoreceptors (8).
Although in most vertebrate retinas, cones are much less
abundant than rods, the chicken retina is cone-dominant. In
this species, cones outnumber rods six to one in the central
retina and three to one in the peripheral retina (9). Most
previous biochemical studies of the cone PDE6 isoenzyme have
been carried out using bovine retinas due to their large size and
availability. Nevertheless a cDNA predicted from homology
arguments to encode the chicken cone PDE6 -subunit has
been isolated and characterized (10). Similarly a cDNA most
homologous to the bovine PDE6 -subunit cDNA also has been
reported from chicken pineal gland (11).
PDE6 is a member of the 11 families of Class 1 phosphodi-
esterases that hydrolyze cyclic nucleotides. Five of these PDE
families, PDEs 2, 5, 6, 10, and 11, contain one or two complete
GAF domains in their N-terminal regulatory regions (12, 13).
GAF domains are regulatory small molecule-binding domains
originally named for their presence in cGMP-regulated PDEs,
certain adenylyl cyclases and the transcription factor FhlA of
bacteria (14). Cyclic GMP binds to one of two GAF domains of
PDE2, PDE5, and PDE6 (6, 15, 16). The catalytic activity of
PDE2A is allosterically stimulated by cGMP binding to its
GAF-B domain (15). In PDE5, cGMP binding to the GAF-A
domains increases PDE5 catalytic activity and potentiates
phosphorylation at an N-terminal serine (17, 18). The func-
tions, regulation, and roles of GAF domains in PDEs have been
comprehensively reviewed recently (19).
For the amphibian photoreceptor PDE6, it has been found
that cGMP occupancy at a GAF domain enhances P- binding
to the holoenzyme (20, 21). Several roles for cGMP binding
have been proposed. For example, it has been postulated that
non-catalytic cGMP binding to PDE6 may be involved in the
recovery from light stimulation and light adaptation (22). In
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this case, the GAF sites serve as a cGMP reservoir to buffer
cytoplasmic cGMP levels in the dark and accelerate the return
of high cGMP to basal levels upon light activation of the PDE.
Another model suggests that cGMP binding to a GAF domain
regulates the duration of transducin activation of PDE6 by
modulating the affinity of P- (23, 24). These models are not
mutually exclusive.
Recently the three-dimensional structure of the mouse
PDE2A GAF-A/B domains was determined by x-ray diffraction
crystallography at 2.9-Å resolution (25). The regulatory PDE2
GAF-A/B domains form a parallel dimer in which only GAF-B
binds cGMP. There are 11 amino acid residues that make
contact with cGMP and line the binding pocket. In PDE5, 10 of
these 11 residues are identical in GAF-A, which therefore al-
lowed the prediction that this would be the cGMP-binding
domain of this PDE (25). It was subsequently confirmed that
GAF-A of PDE5 is sufficient for high affinity cGMP binding
(26). A consensus cGMP-binding motif, based on the similarity
between PDE2A GAF-B and PDE5 GAF-A domains, has been
proposed (Sequence 1, Ref. 25). Mutagenesis in this motif in
PDE5 suggested that the Phe in the FD dyad of PDE5 GAF-A
domain is essential for cGMP binding (27). A similar finding
has also been shown for the PDE2A GAF-B domain (28). Eight
of the 11 residues in mouse PDE2A, (i.e. Ser-424, Phe-438,
Asp-439, Val-484, Asp-485, Thr-488, Thr-492, and Glu-512)
contact cGMP via side chains. The crystal structure of PDE2
GAF-B and recent mutagenesis studies suggest that its ability
to discriminate cGMP versus cAMP is largely determined by
Asp-439, which provides positive specificity for cGMP binding
via hydrogen bonds between its main chain NH, side chain
carboxyl, and the O-6 and N-1 positions of the guanine base of
cGMP (25). This residue also provides a negative determinant
for cAMP (28).
Compared with PDE2 and PDE5, most PDE6s have both
higher binding affinity and higher specificity for cGMP (6, 29).
Bovine rod PDE6 binds cGMP with Kd values reported from 25
to 500 nM at a low affinity binding site (23) and 500 pM at a
high affinity site (30). Bovine cone PDE6C appears to have one
type of cGMP-binding site with a Kd of about 10 nM (7). A
chimeric bovine PDE6C/PDE5 enzyme also has been reported
to contain a single class of non-catalytic cGMP-binding sites
with a Kd of 450 nM (31).
In this study we report on the bacterial expression of the
tandem GAF domains of chicken cone PDE6 and show that the
basic features of the cGMP-binding pocket is highly conserved
between the cone PDE6C and mouse PDE2A GAF domains. We
demonstrate that GAF-A instead of GAF-B contains the single
high affinity cGMP-binding domain of PDE6C and that the
conserved residues of PDE6C (Phe-123, Asp-169, Thr-172, and
Thr-176) each appear to play significant roles in forming a
functional cGMP-binding pocket. Finally we report on the iso-
lation and characterization of the chicken PDE6 holoenzymes
and show that their cGMP binding characteristics are similar
to those of the isolated chicken GAF domains and also to their
corresponding mammalian PDE6 counterparts.
EXPERIMENTAL PROCEDURES
Materials
Chicken eyes were obtained from the Tyson Co. (Little Rock, AK).
Bovine eyes were purchased from Schenk Packing (Stanwood, WA).
[3H]cGMP was obtained from Amersham Biosciences; cGMP, 3-isobu-
tyl-1-methylxanthine (IBMX), isopropyl -thioglucopyranoside were
from Sigma. Pfu DNA polymerase and the QuikChange® site-directed
mutagenesis kits were obtained from Stratagene (La Jolla, CA). Restric-
tion enzymes were purchased from New England Biolabs (Beverly, MA).
Methods
Isolation and Initial Purification of Chicken Rod and Cone PDE6
Holoenzyme—In a typical experiment 50–100 chicken retinas were
dissected in the light, separated from much of the vitreous humor, and
homogenized in hypotonic buffer (10 mM Tris, pH 7.5, 1 mMMgCl2, 1 mM
dithiothreitol, and 0.2 mM phenylmethylsulfonyl fluoride) using a dozen
strokes of a motor-driven Teflon pestle in a glass homogenizer (Potter-
Elvehjem tissue grinder). The homogenate was centrifuged at
100,000  g for 1 h. The supernatant was applied to a 75-ml DE52
anion-exchange column and eluted with a linear NaCl gradient (20–300
mM NaCl, 10 mM Tris, pH 7.5, 1 mM MgCl2) run at a flow rate of 1
ml/min at 4 °C. Sixty fractions of 5 ml each were collected at 4 °C and
assayed for histone-activated (2.5 mg/ml, type VIII-S) phosphodiester-
ase activity by measuring the release of phosphate (7).
cGMP Affinity Column Purification of Chicken PDE6 Holoenzyme—
Two histone-activated PDE activity peaks of approximately equal ac-
tivity were separated on the DE52 anion-exchange column. Approxi-
mately 35 ml of the first histone-activated PDE6 peak was pooled and
loaded onto an epoxy-Sepharose cGMP affinity column (7, 15). The
column was washed two times with low salt buffer (20 mM Tris, pH 7.5,
200 mM NaCl, 10 mM dithiothreitol, 0.1 mM EDTA, and 1 mM phenyl-
methylsulfonyl fluoride), and the cGMP-binding proteins, including
chicken photoreceptor PDE, were eluted with 1 mM cGMP in the pres-
ence of 2 mM EDTA and 1 mM IBMX in low salt buffer at room temper-
ature. The presence and purity of chicken photoreceptor PDEs were
analyzed by SDS-PAGE and silver staining.
Immunoprecipitation of Chicken PDE6s—It has been shown previ-
ously that the ROS-3 monoclonal antibody recognizes both rod and cone
photoreceptor PDE from bovine retina (32). The putative chicken cone
and rod PDE6 holoenzymes, corresponding to the first or the second
histone-activated PDE6 peaks, were immunoprecipitated using the
ROS-3 monoclonal antibody bound to Protein G. Typically 15 ml of the
DE52 fraction of either chicken rod or cone PDE was mixed with 200 l
of antibody resin (500 g of antibody bound to 200 l of Protein G
PLUS-agarose beads (Santa Cruz Biotechnology, Inc.) for 1 h at 4 °C) in
the presence of 150 mM NaCl. After mixing overnight, the resin was
pelleted and washed three times with 1 ml of 10 mM Tris, pH 7.5, 1 mM
MgCl2, 300 mM NaCl at 4 °C.
Identification of Chicken Rod and Cone PDE6 Using Mass Spectrom-
etry—On-line nano-liquid chromatography/electrospray ionization-
MS/MS experiments were performed on an API-US quadrupole time-of-
flight mass spectrometer (Micromass) equipped with the CapLC system
(Waters, Milford, MA). The stream select module was configured with an
OPTI-PAK Symmetry300 C18 trap column (Waters) connected in series
with a nanoscale analytical column (75-m inner diameter  15 cm,
packed with 3.5 m, XTerra MS C18 particles (Waters)).
The eluate from the cGMP affinity column was concentrated to 100
g/ml using a Centriprep centrifugal filter (Millipore) and then digested
with 5 g/ml trypsin. In other experiments immunoprecipitated pro-
teins were separated by SDS-PAGE and stained with Coomassie Blue.
The protein bands corresponding to the molecular weights of rod and
cone PDE6 were sliced out from the gel and digested with trypsin for
analysis by mass spectrometry (33). Protein digests (5 l) were injected
onto the trap column at 10 l/min, desalted, and back-flushed to the
analytical column at 0.5 l/min using a gradient elution. The gradient
consisted of 5–50% solvent B for 30 min followed by 50% B for 15 min
and 50–90% B for 5 min (A 5% acetonitrile, 0.1% formic acid; B 95%
acetonitrile, 0.1% formic acid).
Quadrupole time-of-flight parameters were set as follows: the elec-
trospray potential was set to 3.5 kV, the cone voltage was set to 60 V,
the extraction cone was set to 2 V, and the source temperature was set
to 80 °C. The MS survey scan wasm/z 400–1600 with a scan time of 1 s,
and the collision energy was set to 10 eV. When the intensity of a
peptide peak rose above a threshold of 20 counts, tandem mass spectra
were acquired using the data-dependent algorithm implemented in the
MassLynx acquisition software. For operation in the MS/MS mode, the
scan time was increased to 2 s, the isolation width was set to include
the full isotopic distribution of each peak (3 Da), and the collision
energy was set to 15–25 eV. MS/MS spectra were recorded for the
doubly, triply, and quadruply charged molecular ions of peptides. All
MS/MS spectra were searched against the non-redundant National
Center for Biotechnology Information protein data base by using MAS-
COT (34) assuming a mass tolerance of 0.3 Da for both the precursor
and the fragment ions.
SEQUENCE 1
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cGMP Binding to the Chicken Rod and Cone PDE6 Holoenzymes—
Chicken cone PDE6 holoenzyme was immunoprecipitated as described
previously except less sample and antibody were used. Usually 1–2 ml
of DE52 fraction of chicken rod or cone PDE was mixed with 100–200 l
of antibody resin (100–200 g of antibody). After incubation overnight,
the resin was collected by centrifugation and washed three times with
1 ml of 10 mM Tris, pH 7.5, 1 mM MgCl2, 300 mM NaCl. The PDE
immunoprecipitates were then incubated with 5 mM Tris, pH 7.5, 25 mM
NaCl, 2 mM EDTA, 1 mM IBMX, 0.1 mg/ml bovine serum albumin,
2–600 nM (7.5 Ci/mmol) [3H]cGMP (200-l total volume) for 2 h at room
temperature. [3H]cGMP bound to the immunoprecipitated PDE was
separated from free ligand by filtration on Millipore filters (0.45-m
HA). The Millipore filters were dissolved in Filter-Count® complete
liquid scintillation counting mixture (PerkinElmer Life Sciences) over-
night and counted in a Packard 1600 TR liquid scintillation analyzer.
cGMP Binding and cAMP Binding by Individual Chicken Cone PDE6
GAF Domain Proteins—The binding of cGMP or cAMP to GAF domain
proteins was analyzed by the Millipore filter binding assay as described
previously (37) usually as a competition assay (28). For the cGMP
binding competition assays, 1 nM GAF domain protein was incubated
with a fixed amount of [3H]cGMP (usually 1 nM) and various amounts
of unlabeled cGMP from 2 to 600 nM for 2 h at room temperature. For
the cAMP binding competition assays, 1 nM GAF domain protein was
incubated with 1 nM [3H]cGMP and various amounts of unlabeled cAMP
from 1 M to 100 mM for 2 h at room temperature.
Most Kd values reported in this study were determined by the ho-
mologous or heterologous displacement methods. Care was taken to
utilize concentrations of protein that were lower than the measured Kd
so that the data represented true binding curves and not a titration
analysis. Similarly for all IC50 determinations the concentrations of
labeled radioligand was adjusted to be lower than the measured IC50
value so that the IC50 approached the Ki for the cold ligand (35, 36).
Therefore, the affinity of the ligand can be calculated using the equation
of Cheng and Prusoff (35) that states that the equilibrium dissociation
constant of the ligand, Ki  IC50/(1  [Radioligand]/Kd). In the case of
homologous displacement, e.g. [3H]cGMP being displaced by cGMP, the
equation further simplifies to Ki  IC50  [Radioligand] since Ki  Kd.
Curve fitting was done using GraphPad Prism4 with a one-site compe-
tition model constraining the 100 and 0% binding points. Better fits
were not obtained with a multiple site model.
Enzyme Kinetics of Chicken Rod and Cone PDE6 Holoenzymes—The
kinetics for both cGMP and cAMP hydrolysis of the chicken rod and
cone PDE6 were determined using fractions from the ion-exchange
column. PDE6 activity was assayed in the presence of histone (2.5
mg/ml, type VIII-S, Sigma) by PDE activity assay using either
[3H]cGMP or [3H]cAMP as substrate (15, 32). The Km values for cGMP
and cAMP hydrolysis were derived by nonlinear regression analysis
using GraphPad Prism® from data points obtained using 1–250 M
[3H]cGMP or 50–2500 M [3H]cAMP as substrate.
Three-dimensional Structure Model of Chicken Cone PDE6 GAF-A
Domain—A three-dimensional model for the chicken PDE6 GAF-A
domain was constructed based upon the crystal structure of the mouse
PDE2A GAF-B domain using the Swiss-Model program (38). Sequence
alignments were made with the ClustalW program (39). After adding
side chains from a rotamer data base, the working model was energy-
minimized using GROMOS 96 (38).
Cloning, Expression, and Purification of the GAF Domains of Chicken
Cone PDE6—The pRunH plasmid (a derivative of the pMW172 vector
(40)) containing a C-terminal His6 tag was used as an expression vector
for the GAF-A, GAF-B, and GAF-A/B domains of chicken PDE6C.
Full-length chicken PDE6C cDNA was a generous gift from Dr. Semple-
Rowland (University of Florida). The boundaries of GAF-A/B, GAF-A,
and GAF-B domain constructs were amino acids 42–458, 42–238, and
248–458, respectively, based on homology alignment with other PDE
GAF domains. DNA coding for these domains was PCR-amplified using
the full-length chicken PDE6C as template and primers containing
BamHI and XhoI sites. The PCR products were ligated into the pRunH
vector downstream of the T7 promoter.
Chicken cone PDE6 GAF domain constructs were transformed into
C41 competent Escherichia coli. Protein expression was induced by
isopropyl -thioglucopyranoside at 16 °C, and cells were grown over-
night. The cell pellets were resuspended in lysis buffer (100 mM NaCl,
20 mM Tris, pH 7.5, 1 mM MgCl2, 10 g/ml DNase I, 1 g/ml leupeptin,
1 g/ml pepstatin) and disrupted through either a French Press or a
Microfluidizer® cell disruption apparatus. The lysates were centrifuged
at 10,000  g for 1 h at 4 °C, and the supernatant was incubated with
Talon® resin (Clontech) for 2 h at 4 °C. The bound His6-tagged proteins
were eluted with buffer containing 150 mM imidazole, 50 mM sodium
phosphate (pH 7.0), and 300 mM NaCl. The eluted proteins were con-
centrated using a Centriprep centrifugal filter (Millipore) and subjected
to gel filtration using a Superose-12 column (Amersham Biosciences) to
remove aggregated protein and determine the apparent molecular
weight of the GAF proteins. SDS gel electrophoresis was carried out to
determine the purity of the isolated GAF domain proteins.
Site-directed Mutagenesis Studies on Chicken Cone PDE6C GAF-A
and GAF-A/B Domains—The QuikChange site-directed mutagenesis
kit (Stratagene) was used to make point mutations in chicken cone
PDE6 GAF-A and GAF-A/B cDNA constructs. E. coli XL-blue competent
cells were used for transformations, and the mutant cDNAs were puri-
fied by QIAprep® spin miniprep kit (Qiagen, Valencia, CA). All mutant
cDNAs were sequenced to ensure the proper in-frame subcloning and
the desired mutation.
RESULTS
Modeling of the Chicken Cone PDE GAF-A Domain—Se-
quence alignments between the GAF-A and GAF-B domains of
chicken PDE6C to GAF-B of mouse PDE2A showed that the
GAF-A domain of PDE6 had very high homology to PDE2A
GAF-B and therefore that the basic architecture of the cGMP-
binding pocket might be conserved (Fig. 1A). Of eight side
chains known to contact cGMP in PDE2 GAF-B, five are iden-
tical in PDE6C GAF-A, and three of these are in the helix -4
(H4) of PDE2A GAF-B. In addition, Asp-439 of mouse PDE2A
GAF-B is conserved as Glu-124 in chicken PDE6C GAF-A. A
three-dimensional homology model of chicken cone PDE6
GAF-A based upon the crystal structure of PDE2A GAF-B
domain is shown in Fig. 1B. Because of gaps generated by the
homology alignment of the two GAF sequences, two extra in-
sertions are introduced as solvent-exposed loops in the modeled
structure of chicken cone PDE6 GAF-A. Since both sequences
are relatively hydrophobic this does not seem unreasonable.
The first insertion resides between the first -helix and the
first -sheet strand. The second insertion is located between
the first and second -strand. Neither of the two insertions
interrupts the secondary structure of the model. For the rest of
the sequence, the overall folds of the chicken PDE6C GAF-A
domain are very similar to that of mouse PDE2A GAF-B. Fi-
nally a putative hydrogen bonding pattern based on the homol-
ogy model is shown in Fig. 1C. This is discussed in more detail
later.
The GAF-A Domain Contains the High Affinity cGMP-bind-
ing Site—The crystal structure of the mouse PDE2A GAF do-
mains showed that GAF-B but not GAF-A binds cGMP (25).
However, the sequence alignment and homology model sug-
gested that in PDE6C, GAF-A should bind cGMP. To test this
prediction, three different chicken cone GAF domains, GAF-A,
GAF-B, and GAF-A/B, were successfully expressed as soluble
proteins in E. coli. Each could be purified by Talon resin and gel
filtration HPLC to achieve 98% purity (Fig. 2, A and B).
These proteins appeared to be properly folded as they were
soluble and eluted as single symmetrical peaks on the sizing
column. Binding studies for cGMP on the purified GAF domain
proteins showed that both GAF-A/B and GAF-A possessed a
single high affinity binding site with Kd values of about 10 nM
(Fig. 2, C and D). However, the GAF-B domain did not bind
cGMP (data not shown). Thus, the GAF-A domain appears to
contain the only high affinity cGMP-binding site of chicken
cone photoreceptor PDE as is also the case for PDE5 (16).
Separation and Identification of Chicken Cone and Rod
PDE6—Unfortunately the PDE6C GAF domains only from
chicken but not other species (bovine and human) could be
expressed as a functional protein in our bacterial system.
Therefore, to evaluate the relevance of cGMP binding proper-
ties of the bacterially expressed GAF domain, it was essential
to understand the cGMP binding characteristics of the chicken
PDE6C holoenzyme, which had not previously been studied.
Consequently we first needed to identify and isolate chicken
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rod and cone PDE6 holoenzyme. Starting with crude extracts
from partially dissected chicken retinas, two histone-activated
peaks of PDE activity were separated by DE52 anion-exchange
chromatography (Fig. 3A). Comparison of the chromatography
profiles showed that the first and second peaks of activity
superimposed with the major peaks of activity from bovine
retina (Fig. 3A). In the bovine retina these peaks are known to
correspond to cone and rod PDE6, respectively (6).
However, the observation that the two PDE6 activities
eluted at the same salt gradient concentrations as the bovine
FIG. 1. A, sequence homology align-
ment between chicken cone PDE6 GAF-A
domain and mouse PDE2A GAF-B do-
main. The homology alignment was per-
formed using ClustalW (39). The black
arrows indicate the 6 conserved residues
in close contact with cGMP. Two gaps be-
tween the homology sequence are under-
lined in black. The conserved residues of
H4 are underlined in red. B, three-dimen-
sional model of chicken cone PDE6
GAF-A cyclic GMP-binding pocket based
on the crystal structure of mouse PDE2A
GAF-B. The model was produced using
the Swiss-Model program (38). The green
ribbon indicates the location of H4 of
chicken cone PDE6 GAF-A. The model il-
lustrates the position of the residues al-
tered by mutagenesis including the 3 con-
served cGMP-contacting residues located
on helix 4 (Asp-169, Thr-172, and Thr-
176). These residues are oriented toward
cGMP and could potentially form hydro-
gen bonds directly or through a water
molecule with cGMP. The phenyl ring of
Phe-123 base-stacks with the guanine
ring of cGMP. C, LigPlot showing proba-
ble hydrogen bond interactions with
cGMP. gg, Gallus gallus; mm, Mus mus-
culus; bt, Bos taurus.
FIG. 2. A, superose-12 HPLC purification of chicken cone PDE6 GAF-A. Partially purified chicken cone PDE6 GAF-A domain protein (from the Talon
affinity resin) was applied to a Superose-12 HPLC sizing column. The column was run at 0.5 ml/min, and 0.5-ml fractions were collected. The major
protein peak eluted at an apparent molecular mass of about 50 kDa corresponding to a GAF-A dimer (assuming a globular shape). B, SDS-PAGE of
Superose-12-purified chicken cone PDE6 GAF-A. Chicken cone PDE GAF-A domain protein was purified by Talon resin and subsequent Superose-12
sizing column. Superose-12 fractions 20–32 corresponding to the GAF-A protein peak were analyzed by SDS-PAGE and Coomassie Blue staining. The
purity of GAF domain proteins was98% as quantified using NIH Image. C and D, cGMP binding to chicken cone PDE6 GAF-A and GAF-A/B. cGMP
binding competition assays were carried out on chicken cone PDE6GAF-A andGAF-A/B proteins. 1 nMGAF protein was incubated with 1 nM [3H]cGMP
and various amounts of unlabeled cGMP ranging from 2 to 600 nM. TheKd values (determined as IC50 values) for cGMP binding to GAF-A and GAF-A/B
were 21  4 nM (n  7) and 10  3 nM (n  5), respectively. Values are given as the mean  S.E.
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cone and rod PDE6 isozymes did not unambiguously verify the
identity of the first peak as the chicken cone and the second
peak as the chicken rod enzyme. Therefore, each peak was
further analyzed by cGMP affinity column chromatography or
by immunoprecipitation followed by mass spectrometry. Only
the first peak bound to a cGMP affinity column as is the case for
the bovine cone isoenzyme (7). However, both peaks could be
absorbed to the ROS-3 antibody. The presence and purity of the
chicken photoreceptor PDE6 in either the eluate from the
cGMP affinity column or the immunoprecipitated pellets were
assessed by silver or Coomassie stain of SDS-polyacrylamide
gels (Fig. 4, A1 and B1).
To positively identify the first peak as chicken cone PDE6,
the protein eluted from the cGMP affinity column was trypsin-
digested and analyzed by mass spectrometry. Thirteen pep-
tides larger than 2 amino acids from the MS/MS spectra were
exact matches with the chicken cone PDE6 -subunit. No
other large PDE peptides were identified. Thus, the first his-
tone-activated PDE6 activity peak off the DE52 ion-exchange
column contains chicken cone PDE6 (Fig. 4A2).
However, since the putative rod PDE6 did not bind to the
cGMP affinity column and could not be purified by this method,
both PDE activity peaks from the DE52 column were further
purified by immunoprecipitation with ROS-3 monoclonal anti-
body. In this case, the immunoprecipitation pellets were sepa-
rated by SDS-PAGE and stained with Coomassie Blue. The
protein bands corresponding in size to the major subunits of
PDE6 were trypsin-digested and analyzed by mass spectrome-
try (Fig. 4B1).
Seventy MS/MS spectra were acquired during a 45-min liq-
uid chromatography/MS/MS run using data-dependent selec-
tion of the doubly, triply, and quadruply charged peptide pre-
cursors. Upon manual inspection 37 low quality MS/MS spectra
with ion intensities below 20 counts were discarded. The re-
maining 33 MS/MS spectra were searched against the non-
redundant National Center for Biotechnology Information pro-
tein data base using the MASCOT search engine. The search
produced 12 matches to tryptic fragments of chicken rod
PDE6B and nine matches to common protein contaminants
(keratins and trypsin). The remaining 12 good quality MS/MS
spectra (with ion intensities of at least 20 counts) were sub-
jected to manual de novo sequencing, and all of them could be
assigned to chicken rod PDE6B peptides. These peptides were
not identified by the initial data base search because four
contained oxidized methionines, two were non-tryptic frag-
ments, and the other three had more than one missed cleavage.
In addition, one peptide contained an acrylamide-modified cys-
teine, and the N-terminal peptide was shown to be acetylated
by the corresponding MS/MS spectra recorded for the doubly
and triply charges ions of this peptide. Based on these data we
conclude that chicken rod PDE6B was the only major protein
contained in the gel band. The protein coverage obtained by
MS/MS is shown in Fig. 4B2.
In addition, the MASCOT search result indicated that 16
peptides from the putative cone PDE6 protein band (peak 1)
were exact matches with chicken cone -subunit (PDE6C)
(data not shown). Therefore, we confirmed our earlier observa-
tion that the first histone-activated PDE6 activity peak con-
tained the chicken cone PDE6C.
The firm identification of the chicken cone and rod enzymes
allowed us to compare the cGMP binding characteristics of the
holoenzymes in the DE52 fractions with those of the purified
individual GAF domains described earlier. For this we used an
immunoprecipitation method for measurement of cGMP bind-
ing to rod and cone PDEs (6, 30). This method was used to
ensure that all binding measured was due only to the PDE6
and not other nucleotide-binding proteins likely to be in the
DE52 fractions. Pilot experiments with purified chicken GAF
domains (not shown) and earlier studies with bovine PDE6
FIG. 3. A, DE52 ion-exchange column fractionation of the hypotonic
extracts of chicken retina. Methods similar to those described for iso-
lation of bovine PDE6 were used for the chicken PDE6s (44). 100 frozen
chicken retinas were extracted with hypotonic buffer (10 mM Tris, pH
7.5, 1 mM MgCl2, 1 mM dithiothreitol, and 0.2 mM phenylmethylsulfonyl
fluoride). After 100,000  g centrifugation, the retinal supernatant was
applied to a 75-ml DE52 ion-exchange column equilibrated in the hy-
potonic buffer plus 20 mM NaCl and eluted with a linear NaCl gradient
(20–300 mM) run at 1 ml/min at 4 °C. A total of 60 fractions of 5 ml each
was collected and assayed for PDE activity in the presence of 2.5 mg/ml
histone. There are two histone-activated PDE6 activity peaks: rod (R)
and cone (C) PDE6 peaks. B and C, cGMP binding to chicken cone (B)
and rod (C) PDE6 holoenzyme. Chicken rod or cone PDE6 holoenzyme
was immunoprecipitated using ROS-3 monoclonal antibody bound to
Protein G PLUS-agarose resin as described under “Methods.” The im-
munoprecipitated enzyme was incubated with cGMP binding buffer in
the presence of 2 mM EDTA, 1 mM IBMX, and 2–600 nM (7.5 Ci/mmol)
[3H]cGMP in a total volume of 200 l for 2 h at room temperature. After
incubation, samples were subjected to a filter binding assay. The data
shown here are from a single representative experiment that was re-
peated three times. The mean values were 25  5 nM for cone and 7 
3 nM for rod PDE6 (mean  S.E.).
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holoenzymes indicate that this antibody does not alter the
binding properties for cGMP compared with the Millipore
method (30). [3H]cGMP was found to bind to a single class of
high affinity sites on chicken cone PDE6 with a Kd of 25 5 nM
(Fig. 3B). The apparent cGMP binding affinity to the rod PDE6
was slightly higher than that of cone with an apparent Kd value
of 7  3 nM (Fig. 3C). To prevent hydrolysis of cGMP by the
holoenzyme, the immunoprecipitated PDE was incubated with
[3H]cGMP in the presence of 1 mM IBMX and 2 mM EDTA.
The bovine cone PDE6C holoenzyme is reported to exhibit a
single class of high affinity cGMP-binding sites with a Kd of
about 11 nM (6). Thus, chicken cone PDE6C has very similar
non-catalytic cGMP binding characteristics to bovine cone
PDE6C. In addition, the bacterially expressed chicken cone
PDE6C GAF-A/B and GAF-A domains each bound cGMP with
Kd values of	10–20 nM. This is in good accordance with the Kd
value of the holoenzyme suggesting that the isolated GAF
domain proteins provide a reasonable model system for study-
ing the cGMP binding properties of the native enzyme.
Enzyme Kinetics of Chicken Rod and Cone PDE6—Using the
DE52 rod and cone fractions, the kinetic values for both cGMP
and cAMP hydrolysis by chicken rod and cone PDE6 were
determined (Table I). The Km values were 29 9 and 26 5 M
for cGMP and 820  34 and 717  44 M for cAMP for the rod
FIG. 4. A1, SDS-PAGE analysis of
chicken cone PDE6 purified by cGMP af-
finity chromatography. Seven fractions
from the first peak of the DE52 ion-ex-
change chromatography (35 ml) were
pooled together and loaded on an epoxy-
Sepharose cGMP affinity column (15). Af-
ter washing with 15 ml (5 bed volume)
wash buffer (20 mM Tris, pH 7.5, 200 mM
NaCl, 2 mM EDTA, 10 mM dithiothreitol,
1 mM phenylmethylsulfonyl fluoride, and
1 mM IBMX). The cGMP-binding proteins
including chicken cone PDE6 were eluted
with 1 mM cGMP at the presence of 2 mM
EDTA and 1 mM IBMX. The purity of the
eluted protein fractions was analyzed by
silver staining the SDS-polyacrylamide
gels (M, marker; E, eluate; W, wash; F,
flow-through). The arrowhead indicates
the protein band of chicken cone PDE6
-subunit. A2, MS/MS coverage of
chicken cone PDE6 -subunit. Of 862
amino acids from the protein sequence
(GenBankTM accession number I50186),
156 amino acids (shown in bold type) were
verified by MS/MS, indicating an 18%
protein coverage. “_” indicates the proba-
ble trypsin cleavage site. B1, SDS-PAGE
analysis of immunoprecipitated chicken
rod and cone PDE6 holoenzyme. Chicken
rod or cone PDE6 holoenzymes were im-
munoprecipitated using ROS-3 mono-
clonal antibody bound to Protein
G-Sepharose resin. The pellets were ana-
lyzed by Coomassie staining of the SDS-
polyacrylamide gel (M, marker; lane 1,
first PDE6 activity peak off DE52 column;
lane 2, second PDE6 activity peak off
DE52 column. The arrowheads indicate
the protein bands of chicken cone and rod
PDE6. B2, MS/MS coverage of chicken rod
PDE6 -subunit. Of 736 amino acids from
the protein sequence, 249 amino acids
(shown in bold type) were verified by MS/
MS, indicating a 34% protein coverage.
“_” indicates the probable trypsin cleav-
age site. Note several sequences for
chicken PDE6B that do not entirely
agree with each other have been depos-
ited in GenBankTM. The sequence shown
here (GenBankTM accession number
AAO67732) represents the sequence with
the highest number of exact matches with
the MS/MS data.
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and cone enzymes, respectively. These values are very similar
to those determined previously for bovine PDE6s (Table I).
Residues Critical for cGMP Binding Affinity and Specific-
ity—As noted earlier, there are 6 residues that directly bind
cGMP in PDE2 that are identical or highly conserved in
PDE6C. To determine the relative contribution of each residue
to binding, each of the 6 conserved amino acids was mutated to
alanine. Each of these mutations had a negative effect on the
cGMP binding affinity (Fig. 5 and Table II). Both the S97A and
E124A mutants decreased cGMP binding affinity about 5-fold
(Fig. 5). The other four alanine mutants lost cGMP binding
capability completely as shown in Table II.
In mouse PDE2A GAF-B, the side chain of Phe-438 is base-
stacked with the guanine ring of cGMP through - interac-
tions. Phe-123 of chicken PDE6C corresponds to Phe-438 of
mouse PDE2A, and the homology model suggested that the
phenyl ring of Phe-123 might form a similar interaction in
PDE6C (Fig. 1B). When Phe-123 was mutated to either alanine
or tryptophan, cGMP binding was undetectable up to 100 M
[3H]cGMP. However, when Phe-123 was mutated to tyrosine,
the Kd for cGMP binding was about 40 nM, very similar to
wild-type protein. Thus, it appears likely that in cone PDE6C a
- interaction between the phenyl ring of Phe-123 and the
guanine ring of cGMP is formed and is essential for stabilizing
cGMP binding to the chicken cone PDE6C GAF-A domain.
H4 and cGMP Binding—To date, two GAF domain struc-
tures have been elucidated by x-ray crystallography, mouse
PDE2A (25) and yeast YKG9 protein (41). The GAF domain of
YKG9 has no cGMP binding capability. Nevertheless the over-
all folds of these two GAF domains are very similar. However,
in PDE2A GAF-B, between -strands 4 and 5, there is an
additional helix (H4) containing 3 amino acid residues that
make side chain contact with bound cGMP (Fig. 1A; Asp-169,
Thr-172, and Thr-176). All 3 residues are conserved in the
GAF-A domains of PDE6A, PDE6B, and PDE6C and also in
PDE5A. When any of these residues were mutated to alanine,
the GAF domain completely lost its ability to bind cGMP (Table
II and Fig. 1C). As a control, alanine mutations also were
introduced into the solvent-exposed residues (Ser-165, Asp-
166, Lys-170, and Thr-175) of H4 of the homology model. Each
of these alanine mutants retained most of the binding activity
of wild-type GAF protein (Table II) although these residues are
in close proximity to the cGMP-interacting amino acids. Based
on the above observations, we propose that H4 is essential for
cGMP binding and that interactions between each of the 3
conserved amino acid side chains with cGMP is necessary for
high affinity nucleotide binding.
Cyclic Nucleotide Selectivity of Chicken Cone PDE6 GAF
Domain—In contrast to its high affinity binding to cGMP, the
chicken cone PDE6 GAF domain has extremely low affinity for
cAMP with an apparent affinity of 35  11 mM (Fig. 6). The
crystal structure of mouse PDE2A GAF-A/B suggests that Asp-
439 provides a positive specificity determinant for cGMP bind-
ing due to hydrogen bonds between its side chain carboxylate
with the O-6 and N-1 of the guanine base of cGMP (25, 28). This
residue also has a negative effect on cAMP binding in PDE2A
(28). Residue Glu-124 of chicken PDE6C GAF-A corresponds to
Asp-439 of mouse PDE2A GAF-B. Thus, Glu-124 of chicken
PDE6C GAF-A was predicted to contribute to the cGMP bind-
ing specificity of PDE6C. Indeed the alanine mutant E124A
showed a 5-fold decrease in cGMP affinity and 30-fold increase
in cAMP affinity (Fig. 6). However, it is clear that other addi-
tional specificity determinants also must be present as the
mutant protein still maintained a greater than 1000-fold selec-
tivity for cGMP.
DISCUSSION
Identification of Chicken Rod and Cone PDEs—In contrast to
most species, chickens are known to have cone-dominated ret-
inas with up to 85% of the photoreceptors as cones (42). The
DE52 elution profile, histone activation, and kinetic properties
of the chicken photoreceptor PDEs show that the holoenzymes
have enzyme characteristics very similar to the comparable
photoreceptor PDEs of other species such as bovine, human,
and frog. In addition, direct binding studies on the isolated
chicken PDE6C cone GAF domains show that they have very
similar non-catalytic cGMP binding properties of the holoen-
zyme. These results suggest that the basic enzymatic and
cGMP binding characteristic have been greatly conserved be-
tween chicken and bovine PDE6s during evolution and that the
regulation and properties of the chicken PDE6C GAF domains
reported in this study are likely to be relevant to those of
mammalian species.
Subunit Structure of Chicken Rod PDE6—Rod photoreceptor
PDE6s of various species are thought to be composed of a
heterodimer containing two distinct major catalytic subunits:
TABLE I
Apparent Km values for chicken and bovine PDE6 holoenzyme
The Km values for both cGMP and cAMP hydrolysis by chicken rod and cone PDE6 were determined. The data for bovine rod and cone PDE6s
were published previously in our laboratory (6). Data are presented as the means  S.D.
Chicken Bovinea
Cone Rod Cone Rod
Km(cGMP) (M) 26  5 (n  3) 29  9 (n  3) 17  3 (n  6) 17  7 (n  5)
Km(cAMP) (M) 717  44 (n  3) 820  34 (n  3) 610  50 (n  4) ND
b
a Data from Gillespie et al. (6).
b Not determined.
FIG. 5. cGMP binding to chicken cone PDE6 GAF-A/B wild
type, S97A mutant, and E124A mutant. cGMP binding competition
assays were carried out as in Fig. 4. Wild type (closed squares) and two
mutants, S97A (closed triangles) and E124A (closed circles) are shown.
Figure was plotted using Prism4 constraining the 100 and 0% binding
points. A representative experiment is shown. The experiment was
repeated three times, and the mean values  S.E. were 57  9 nM for
E124A, 63  7 nM for S97A, and 10  3 nM for wild type (W/T).
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the - and -subunits. However, our mass spectrometry anal-
ysis of the enzyme of the second DE52 peak from chicken retina
only detected the -subunit of rod PDE6 (PDE6B). Initially we
thought that this was due to the fact that only the -subunit of
chicken cone (PDE6C) and -subunit of chicken rod (PDE6B)
were in the data base (10, 11). However, when all of the ac-
quired MS/MS spectra were searched against all the available
PDE6A sequences from all species in the National Center for
Biotechnology Information data base, no unique PDE6A pep-
tide matches were found. Therefore, one must consider the
possibility that the rod enzyme in chicken does not contain an
-subunit, and its absence may be a unique characteristic of
chicken rod photoreceptor PDE6. It is probably worth noting
that among all the expressed sequence tag cDNAs in the
chicken data base, there are none that are most homologous to
-subunit of any other species. Both observations taken to-
gether strongly suggest that the chicken rod holoenzyme is a
homodimer composed of two -subunits. The functional signif-
icance of this difference in structure remains to be determined.
Specificity for Cyclic Nucleotide Binding to the GAF-A Do-
main of Photoreceptor PDEs—cGMP and cAMP are composed
of phosphate-ribose and purine base moieties. cGMP and cAMP
differ at their purine rings and have different hydrogen bond-
ing potential in the C-2 and C-6 positions of these rings. By
using cGMP analogs, Cote’s group (29) has suggested that
interaction between GAF domain residues and the N-1/O-6
region of the purine ring of cGMP determines the specificity of
cGMP binding of frog PDE6. This proposition was reinforced by
the crystal structure of the mouse PDE2 GAF domain. Indeed
Asp-439 of mouse PDE2A is located in the GAF-B cGMP-
binding pocket and forms two hydrogen bonds; one is between
the main chain NH and O-6 of the guanine ring, and the other
is between the side chain carboxylate and the N-1 position of
cGMP (25).
The affinities for cGMP determined for the individual bacte-
rially expressed chicken PDE6C GAF domains are very similar
to those reported previously for PDE2A and PDE5A with Kd
values around 10 nM (28). Since mutation of the corresponding
conserved residues in PDE6C reduces cGMP affinity, these
data strongly support the validity of the homology model of
PDE6C GAF-A shown in Fig. 1B. Furthermore they suggests a
high similarity of the overall binding pocket structure between
PDE2A, PDE5A, and PDE6C GAF domains. However, this
homology model does not explain the differences in cyclic nu-
cleotide selectivity between PDE6C and PDE2A or PDE5A. In
PDE2A, 3 residues including Phe-438, Asp-439, and Thr-488
have been demonstrated to each be necessary for cAMP/cGMP
selectivity (28). Only 1 residue corresponding to Glu-124 in
PDE6C has been shown in the present study to participate in
nucleotide discrimination. More importantly, the modeled
structure of PDE6C GAF-A does not elucidate what additional
molecular determinants might be likely to produce the much
greater cyclic GMP selectivity of PDE6C compared with
PDE2A and PDE5A. It has been shown previously that cAMP
has very little binding affinity to the non-catalytic cGMP-bind-
ing site of frog PDE6 (29). The same observation was obtained
with our bacterially expressed chicken cone PDE6 GAF pro-
teins. We find nearly a 100,000-fold decreased affinity for
cAMP compared with cGMP in the isolated GAF-A constructs.
The PDE2A and PDE5A GAF domains are reported to have
about 20- and 1000-fold greater selectivity, respectively, for
TABLE II
Effect on cGMP binding affinity by mutation of residues lining the cGMP-binding pocket
Column 2, apparent Kd values for each construct, including wild type and mutants, were derived from at least three individual cGMP binding
experiments with duplicate points and expressed as mean  S.D. Column 3, atom in residue of column 1 closest to the cGMP. CZ, carbon- ; OD,
oxygen- ; OG, oxygen- . Column 4, the distance between cGMP and the amino acid side chain of mouse PDE2A GAF-B domain. For wild type
(W/T) GAF-A/B, n  5; for the mutants, n  3. aa, amino acid; gg, G. gallus; NB, no binding; H4, located on H4 of GAF-A.
aa residue in ggPDE6C GAF-A/B Kd for cGMP






W/T 10  3
Mutations in residues interacting with
guanine ring
F123A NB CZ 3.2
F123W NB CZ 3.2
F123Y 38  5 CZ 3.2
E124A 57  9 OD1 or OD2 2.7
T172A (H4) NB OG1 3.2
Mutations in residues interacting with
phosphate-ribose or imidazole ring
S97A 63  7 OG 2.7
D169A (H4) NB OD2 2.9
T176A (H4) NB OG1 2.8
Mutations in residues not interacting
directly with cGMP
S165A (H4) 103  11
D166A (H4) 178  27
K170A (H4) 70  12
T175A (H4) 79  9
FIG. 6. cAMP binding of GAF-A wild type and E124A mutant.
cAMP binding competition assays were carried out on chicken cone
PDE6 GAF-A wild-type (W/T) and E124A mutant proteins. 1 nM GAF
protein was incubated with 1 nM [3H]cGMP and various amounts of
unlabeled cAMP ranging from 1 M to 100 mM. The IC50 values (mean
S.D.) for cAMP binding were 35  11 mM (n  3) and 1.0  0.3 mM (n 
4) for the wild-type GAF-A and E124A mutants, respectively. Figure
was plotted as described in Fig. 5.
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cGMP versus cAMP, while the chicken PDE6C holoenzyme has
more than 100,000-fold greater selectivity (29, 43). It is also
known that a D439A mutation of PDE2A significantly in-
creases its cAMP binding affinity resulting in similar affinities
for both cAMP and cGMP (28). In the present study the anal-
ogous E124A mutant in PDE6 caused an 	30-fold increased
affinity for cAMP compared with wild type (Fig. 6). Neverthe-
less its absolute binding affinity for cAMP is still more than
1000-fold lower than that for cGMP. Therefore, there must be
additional structural components conferring negative selectiv-
ity for cAMP only for the photoreceptor PDEs. It will likely
require the direct determination of the structure of the PDE6C
GAF-A to learn the molecular basis for this selectivity in the
photoreceptor PDEs.
To our knowledge there have been no previous reports of
high yield bacterial expression of functional bovine PDE6 ei-
ther in its entirety or of its individual domains, although good
expression of several PDE5/PDE6 chimeric molecules has been
reported (31). Therefore, the robust bacterial expression of
chicken cone PDE6 GAF domains has substantial importance
in that it has allowed these basic characterization studies to be
carried out. Moreover, since the characterization of the chicken
PDE6 holoenzymes suggested that the kinetics and binding
properties are greatly conserved between chicken, bovine, and
frog isozymes, our understanding of the regulatory properties
learned from analysis of these domains is likely to be widely
applicable. It is hoped that they will facilitate new insights into
the function and evolution of this unique domain as an essen-
tial unit of various signaling and sensory transducers.
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